08 Jan 2020 Promethera® Announces Initiation of Phase 2b DHELIVER Study of HepaStem™ in Patients with Acute-on-Chronic Liver Failure (ACLF) Member news
07 Jan 2020 Mithra Signs License and Supply Agreement for Commercialization of Tibelia® in Italy Member news
07 Jan 2020 Oxurion NV Reports Positive Topline Data from Phase 1 study evaluating THR-687 for treatment of DME Member news
06 Jan 2020 Mithra Signs LSA with Alvogen for Commercialization of Estelle® in Hong Kong and Taiwan Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us